Arycs Technologies | $24,000,000 | (Mar 13, 2026)
Ezra(2) | $8,000,000 | (Mar 13, 2026)
Freestyle | $10,000,000 | (Mar 13, 2026)
Cagent Vascular
United States
- Wayne, PA
- 22/02/2024
- Series C
- $30,000,000
Cagent Vascular (Wayne, PA) has developed and commercialized its novel angioplasty balloon with Serration Technology to treat blocked arteries in the leg or Peripheral Artery Disease (PAD) and Chronic Limb Threatening Ischemia (CLTI). The Serranator PTA Serration Balloon Catheter is the first and only angioplasty balloon with serration technology
- Industry Medical Equipment Manufacturing
- Website https://cagentvascular.com/
- LinkedIn https://www.linkedin.com/company/cagent-vascular/
Related People
Carol BurnsCo Founder
United States -
Wayne, Pennsylvania
CEO, Serial Entrepreneur, Bold & Strategic, Deep Cardiovascular Knowledge, Tireless Energy, Proven Track Record
Experienced in all phases of medical device development from early stage proof of concept to commercialization. Cardiovascular devices are my passion. I like the fast pace of the start-up world! My past experience, industry relationships and clinical knowledge help me identify technologies that have the best chance for success.
I'm committed to developing devices that will improve patient's lives, that physicians will want to use and that investors will realize a return for their investment.
Mantis Space | $10,000,000 | (Mar 13, 2026)
Monteris Medical | $28,000,000 | (Mar 13, 2026)
Gumloop | $50,000,000 | (Mar 13, 2026)
Combat Medical Ltd | $3,472,639 | (Mar 13, 2026)
Qurrent | $15,000,000 | (Mar 13, 2026)
Waiv, formerly Owkin Dx | $33,000,000 | (Mar 13, 2026)
Carefam | $14,500,000 | (Mar 13, 2026)
Option Circle | $3,000,000 | (Mar 12, 2026)
AgentMail (YC S25) | $6,000,000 | (Mar 12, 2026)